initial public offerings (IPOs) trading on American exchanges

Thursday, June 28, 2018

Neuronetics (STIM) began trading on the Nasdaq on 28 June 2018

Neuronetics is a company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology.

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Full Time Employees: 145
  • Headquarters: Malvern, PA
  • Founded: 2003

Opened for trading at $25 after pricing IPO at $19

No comments:

Post a Comment